Aurora Cannabis Operating Cash Flow 2011-2026 | ACB

Annual Operating Cash Flow Aurora Cannabis

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16 M	-68.5 M	-116 M	-110 M	-211 M	-338 M	-192 M	-81.7 M	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from annual reports

Maximum	Minimum	Average
16 M	-338 M	-138 M

Quarterly Operating Cash Flow Aurora Cannabis

2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
16 M	-	-	-	-68.5 M	-116 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
16 M	-116 M	-56.1 M

Operating Cash Flow of other stocks in the Drug manufacturers industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Evoke Pharma EVOK	-5.46 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	-435 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	-11.4 M	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	-19.1 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.9 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	-99.2 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-9.58 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	-14.3 M	-	-	$ 142 M	USA
Cumberland Pharmaceuticals CPIX	4.93 M	$ 5.57	0.72 %	$ 82.7 M	USA
Cronos Group CRON	25.9 M	$ 2.74	2.43 %	$ 1.05 B	Canada
Harrow Health HROW	43.9 M	$ 32.59	5.59 %	$ 1.2 B	USA
Athenex ATNX	-131 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	-46.9 M	-	-	$ 2.06 B	France
Catalent CTLT	268 M	-	-	$ 11.5 B	USA
HEXO Corp. HEXO	-43.1 M	-	2.45 %	$ 38.1 M	Canada
Organogenesis Holdings ORGO	-10.3 M	$ 2.61	2.35 %	$ 331 M	USA
Eagle Pharmaceuticals EGRX	50.7 M	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	435 M	-	-	$ 28.9 M	Irlanda
Bausch Health Companies BHC	1.03 B	$ 5.45	-0.73 %	$ 1.99 B	Canada
Pacira BioSciences PCRX	189 M	$ 23.55	2.37 %	$ 1.09 B	USA
Canopy Growth Corporation CGC	-166 M	$ 1.08	4.85 %	$ 116 M	Canada
Solid Biosciences SLDB	-156 M	$ 6.56	1.39 %	$ 574 M	USA
Sonoma Pharmaceuticals SNOA	-88 K	$ 1.05	-1.87 %	$ 1.3 M	USA
Jupiter Wellness JUPW	-6.4 M	-	-	$ 33.6 M	USA
Lannett Company LCI	-7.12 M	-	1.15 %	$ 7.11 M	USA
Tilray TLRY	7.91 M	$ 5.45	0.74 %	$ 3.37 B	Canada
OrganiGram Holdings OGI	3.87 M	$ 1.14	6.07 %	$ 109 M	Canada
Evolus EOLS	-42.3 M	$ 6.49	-1.59 %	$ 418 M	USA
Sundial Growers SNDL	-155 M	$ 1.47	1.74 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	-206 M	$ 8.33	1.9 %	$ 426 M	USA
Veru VERU	-30 M	$ 2.21	1.84 %	$ 32.4 M	USA
Neoleukin Therapeutics NLTX	-77.2 M	-	-	$ 193 M	Canada
cbdMD YCBD	-1.45 M	$ 0.77	4.63 %	$ 3.1 M	USA
Assertio Holdings ASRT	-28.2 M	$ 23.4	-0.17 %	$ 150 M	USA
ProPhase Labs PRPH	28.6 M	-	-	$ 5.07 M	USA
Radius Health RDUS	-22.4 M	-	-	$ 1.42 B	USA
PetIQ PETQ	61.9 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	-45.8 M	$ 7.23	0.84 %	$ 285 M	USA
Recro Pharma REPH	-1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	-20.5 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	-5.28 M	$ 0.71	6.86 %	$ 35.5 M	USA
PLx Pharma PLXP	-32.1 M	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	2.32 B	$ 16.43	-0.93 %	$ 19.2 B	USA
Zomedica Corp. ZOM	-17.6 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	-23 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	-659 K	$ 0.79	-3.09 %	$ 28.4 M	USA
Tricida TCDA	-140 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	148 K	$ 0.76	7.69 %	$ 3.26 M	China
TherapeuticsMD TXMD	-159 M	$ 2.06	-0.96 %	$ 23.8 M	USA